Egsmose Emilie Lund, Birkvig Mette, Buhl Thora, Madsen Ole Rintek
Department of Rheumatology and Osteoporosis Clinic/C, Copenhagen University Hospital Gentofte, 2900, Hellerup, Denmark.
Clin Rheumatol. 2015 Jul;34(7):1265-72. doi: 10.1007/s10067-014-2640-0. Epub 2014 May 14.
The Fracture Risk Assessment Tool (FRAX) has been developed by the World Health Organization to evaluate the 10-year risk of a hip fracture and a major osteoporotic fracture. We examined the agreement between fracture risk calculated with and without femoral neck bone mineral density (BMD) in individual patients and the impact of BMD measurement side. Bilateral femoral neck BMD results obtained by dual-energy X-ray absorptiometry and clinical risk factor data from 140 women (age 66 ± 8 years) with a recent distal forearm fracture were used for FRAX analyses. Discrepancies between pairs of risk assessments were analysed by the Bland-Altman method. Agreement on the individual level was expressed as 95% limits of agreement (LoA) and on the group level as the mean (or median) of intra-individual differences (the bias). The femoral neck T-score was -1.69 ± 0.87 (hip with lowest BMD value). The risk of a major fracture and a hip fracture based on the lowest femoral neck BMD value was 23.8 ± 21.4% and 7.6 ± 8.3%, respectively. For major fracture risk assessed without versus with the lowest BMD value, lower and upper LoA were -12.3 and 21.1 percentage points (pp) (bias 4.4 pp, p < 0.0001). The corresponding LoA for hip fracture risk were -11.6 and18.6 pp (bias 3.5 pp, p < 0.0001). LoA for major fracture risk assessed with the lowest versus the highest BMD value were 0.0 and 9.5 pp (bias 2.0, p < 0.0001), and correspondingly for hip fracture risk 0.0 and 9.5 pp (bias 1.0 pp, p < 0.0001). Intra-individual differences increased with increasing fracture risk. In conclusion, the 10-year fracture risk calculated without BMD was on the average slightly overestimated compared to calculations with BMD. On the individual patient level differences between fracture risk assessments with and without BMD were pronounced. The side of BMD measurement may also significantly influence the risk assessment result in individual patients.
世界卫生组织开发了骨折风险评估工具(FRAX),用于评估髋部骨折和主要骨质疏松性骨折的10年风险。我们研究了个体患者中使用和不使用股骨颈骨密度(BMD)计算的骨折风险之间的一致性,以及BMD测量部位的影响。通过双能X线吸收法获得的双侧股骨颈BMD结果以及来自140名近期发生桡骨远端骨折的女性(年龄66±8岁)的临床风险因素数据用于FRAX分析。采用Bland-Altman方法分析成对风险评估之间的差异。个体水平的一致性用95%一致性界限(LoA)表示,组水平用个体内差异的均值(或中位数)(偏差)表示。股骨颈T值为-1.69±0.87(BMD值最低的髋部)。基于最低股骨颈BMD值的主要骨折和髋部骨折风险分别为23.8±21.4%和7.6±8.3%。对于不使用与使用最低BMD值评估的主要骨折风险,较低和较高的LoA分别为-12.3和21.1个百分点(pp)(偏差4.4 pp,p<0.0001)。髋部骨折风险的相应LoA为-11.6和18.6 pp(偏差3.5 pp,p<0.0001)。使用最低与最高BMD值评估的主要骨折风险的LoA为0.0和9.5 pp(偏差2.0,p<0.0001),髋部骨折风险相应为0.0和9.5 pp(偏差1.0 pp,p<0.0001)。个体内差异随骨折风险增加而增大。总之,与使用BMD计算相比,不使用BMD计算的10年骨折风险平均略有高估。在个体患者水平上,使用和不使用BMD的骨折风险评估之间存在明显差异。BMD测量部位也可能对个体患者的风险评估结果产生显著影响。